Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Final research-target dose 2.4 mg + 2.4 mg weekly Titration length ~16 weeks Trial duration 68 weeks (REDEFINE 1 / REDEFINE 2) Route Subcutaneous, once weekly Compound Delivery: 2.4 mg / 2.4 mg Maintenance Pre-blended vials simplify weekly administration to a single injection but lock the ratio at 1:1
Modulate immune responses
These include the use of acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs), other disease-modifying agents for rheumatoid arthritis, and physical therapy
For tirzepatide mechanism, clinical outcomes, and safety evidence, see the Tirzepatide clinical guide
US$ 23.98
US$ 26.70
US$ 22.11
US$ 26.22
US$ 29.12
US$ 22.33
